NCLEX RN Practice Question # 924

NCLEX Examination.

Practice Question # 924.


nclex examination.


Hydromorphone Pharama Review:


Moderate to severe pain


Binds with opioid receptors in the CNS, altering perception of and emotional response to pain. Also suppresses the cough reflex by direct action on the cough center in the medulla.


  • CNS: sedation, somnolence, clouded sensorium, dizziness, euphoria, light-headedness, insomnia, headache, pain CV: hypotension, flushing, bradycardia, edema
  • EENT: blurred vision, diplopia, nystagmus
  • GI: nausea, vomiting, constipation, diarrhea, ileus, dry mouth
  • Respiratory: respiratory depression, bronchospasm


Reassess patient’s level of pain at least 15 and 30 minutes after administration. For better effect, give drug before patient has intense pain. Discontinue all other extended-release opioids before giving extended-release form of hydromorphone. Monitor respiratory and circulatory status and bowel function. Keep opioid antagonist (naloxone) available. Don’t use extended-release form within 14 days of stopping MAO inhibitor. Don’t confuse hydromorphone with morphine or oxymorphone or Dilaudid with Dilantin.

Leave a Reply